These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 25077395)

  • 1. Update on latent tuberculosis infection.
    Hartman-Adams H; Clark K; Juckett G
    Am Fam Physician; 2014 Jun; 89(11):889-96. PubMed ID: 25077395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-γ release assays for diagnosis of tuberculosis infection and disease in children.
    Starke JR;
    Pediatrics; 2014 Dec; 134(6):e1763-73. PubMed ID: 25422024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tuberculosis Infection in Children and Adolescents: Testing and Treatment.
    Nolt D; Starke JR
    Pediatrics; 2021 Dec; 148(6):. PubMed ID: 34851422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in diagnosis and treatment of latent tuberculosis infection.
    Chapman HJ; Lauzardo M
    J Am Board Fam Med; 2014; 27(5):704-12. PubMed ID: 25201941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries.
    Getahun H; Matteelli A; Abubakar I; Aziz MA; Baddeley A; Barreira D; Den Boon S; Borroto Gutierrez SM; Bruchfeld J; Burhan E; Cavalcante S; Cedillos R; Chaisson R; Chee CB; Chesire L; Corbett E; Dara M; Denholm J; de Vries G; Falzon D; Ford N; Gale-Rowe M; Gilpin C; Girardi E; Go UY; Govindasamy D; D Grant A; Grzemska M; Harris R; Horsburgh CR; Ismayilov A; Jaramillo E; Kik S; Kranzer K; Lienhardt C; LoBue P; Lönnroth K; Marks G; Menzies D; Migliori GB; Mosca D; Mukadi YD; Mwinga A; Nelson L; Nishikiori N; Oordt-Speets A; Rangaka MX; Reis A; Rotz L; Sandgren A; Sañé Schepisi M; Schünemann HJ; Sharma SK; Sotgiu G; Stagg HR; Sterling TR; Tayeb T; Uplekar M; van der Werf MJ; Vandevelde W; van Kessel F; van't Hoog A; Varma JK; Vezhnina N; Voniatis C; Vonk Noordegraaf-Schouten M; Weil D; Weyer K; Wilkinson RJ; Yoshiyama T; Zellweger JP; Raviglione M
    Eur Respir J; 2015 Dec; 46(6):1563-76. PubMed ID: 26405286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concordance of a positive tuberculin skin test and an interferon gamma release assay in bacille Calmette-Guérin vaccinated persons.
    Mahan CS; Johnson DF; Curley C; van der Kuyp F
    Int J Tuberc Lung Dis; 2011 Feb; 15(2):174-8, i. PubMed ID: 21219677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in the diagnosis of latent tuberculosis infection.
    Schluger NW
    Semin Respir Crit Care Med; 2013 Feb; 34(1):60-6. PubMed ID: 23460006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Latent tuberculosis infection: Opportunities and challenges.
    Chee CBE; Reves R; Zhang Y; Belknap R
    Respirology; 2018 Oct; 23(10):893-900. PubMed ID: 29901251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of latent tuberculosis infection (LTBI) before anti-TNF-alpha treatment--the tuberculin skin test is useful.
    Goujon C; Nosbaum A; Bensaid B; Rozières A; Nicolas JF; Bérard F
    Eur J Dermatol; 2012; 22(5):701-2. PubMed ID: 23032063
    [No Abstract]   [Full Text] [Related]  

  • 10. Can ELISpot replace the tuberculin skin test for latent tuberculosis?
    Greveson K
    Br J Nurs; 2009 Nov 12-25; 18(20):1248-54. PubMed ID: 20081663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and management of latent tuberculosis.
    Turetz ML; Ma KC
    Curr Opin Infect Dis; 2016 Apr; 29(2):205-11. PubMed ID: 26836374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection and management of latent tuberculosis in liver transplant patients.
    Jafri SM; Singal AG; Kaul D; Fontana RJ
    Liver Transpl; 2011 Mar; 17(3):306-14. PubMed ID: 21384513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of the tuberculin skin test and interferon-γ release assays: an update on the accuracy, cutoff stratification, and new potential immune-based approaches.
    Goletti D; Sanduzzi A; Delogu G
    J Rheumatol Suppl; 2014 May; 91():24-31. PubMed ID: 24788997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon gamma release assays: principles and practice.
    Lalvani A; Pareek M
    Enferm Infecc Microbiol Clin; 2010 Apr; 28(4):245-52. PubMed ID: 19783328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and management of latent tuberculosis infection.
    Hauck FR; Neese BH; Panchal AS; El-Amin W
    Am Fam Physician; 2009 May; 79(10):879-86. PubMed ID: 19496388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Latent M. tuberculosis infection, update 2011].
    Lechartier B; Mazza-Stalder J; Janssens JP; Nicod LP
    Rev Med Suisse; 2011 Nov; 7(318):2289-94. PubMed ID: 22400364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A quantitative benefit-risk analysis of isoniazid for treatment of latent tuberculosis infection using incremental benefit framework.
    Sadatsafavi M; Marra C; Marra F; Moran O; FitzGerald JM; Lynd L
    Value Health; 2013; 16(1):66-75. PubMed ID: 23337217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Tuberculosis screening in school health services in Geneva, Switzerland].
    Meynard A; Pfarrwaller E; Lazarevic CA
    Rev Med Suisse; 2016 Jun; 12(522):1125-8. PubMed ID: 27451510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis of latent tuberculosis infection before initiation of anti-tumor necrosis factor therapy using both tuberculin skin test and QuantiFERON-TB Gold In Tube assay.
    Kim HC; Jo KW; Jung YJ; Yoo B; Lee CK; Kim YG; Yang SK; Byeon JS; Kim KJ; Ye BD; Shim TS
    Scand J Infect Dis; 2014 Nov; 46(11):763-9. PubMed ID: 25195652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and treatment of latent infection with Mycobacterium tuberculosis.
    Chee CB; Sester M; Zhang W; Lange C
    Respirology; 2013 Feb; 18(2):205-16. PubMed ID: 23107218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.